| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/13/2007 | WO2007142608A1 Nucleic acid concatenation |
| 12/13/2007 | WO2007142547A2 Expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide |
| 12/13/2007 | WO2007142540A1 Diagnostic methods and markers |
| 12/13/2007 | WO2007142369A1 Method for screening of anti-obesity agent |
| 12/13/2007 | WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | WO2007142325A1 Preventive or remedy for inflammatory disease |
| 12/13/2007 | WO2007142320A1 AMYLOID-β OLIGOMER, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142300A1 Method of producing lymphocytes |
| 12/13/2007 | WO2007142277A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | WO2007142276A1 Method for determination of secreted heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | WO2007142258A1 Anthocyanin synthesis regulatory gene, and use thereof |
| 12/13/2007 | WO2007142243A1 Mutant and gene encoding the same |
| 12/13/2007 | WO2007142241A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |
| 12/13/2007 | WO2007142210A1 Process for production of optically active alcohol |
| 12/13/2007 | WO2007142208A1 Temperature-responsive protein and polynucleotide, plasmid and cell expressing the temperature-responsive protein and method of using the temperature-responsive protein |
| 12/13/2007 | WO2007142202A1 Method of modifying nucleotide chain |
| 12/13/2007 | WO2007141974A1 Nonhuman model animal of hypertension |
| 12/13/2007 | WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 12/13/2007 | WO2007141912A1 Rna detection method |
| 12/13/2007 | WO2007141790A2 Plant expression constructs and methods of utilizing same |
| 12/13/2007 | WO2007141705A2 Plant promoters |
| 12/13/2007 | WO2007141580A2 Rnase h2 complex and genes therefor |
| 12/13/2007 | WO2007141540A2 Rk2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species |
| 12/13/2007 | WO2007141274A2 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | WO2007141257A1 Lysophosphatidic acid acyltransferase genes and uses thereof |
| 12/13/2007 | WO2007141189A2 Plants having improved growth characteristics and method for making the same |
| 12/13/2007 | WO2007140667A1 A ptd-vp3 fusion protein as anti-tumor medecine and preparing process |
| 12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | WO2007140617A1 Magnetosome gene expression in eukaryotic cells |
| 12/13/2007 | WO2007140599A1 Assessment of risk for colorectal cancer |
| 12/13/2007 | WO2007140590A1 Methods and compositions for inducing bone synthesis |
| 12/13/2007 | WO2007140522A1 Detection and use of antiviral resistance mutations |
| 12/13/2007 | WO2007120989A3 Shade regulatory regions |
| 12/13/2007 | WO2007120533A3 Minigene expression cassette |
| 12/13/2007 | WO2007109564A3 Yeast cell particles as oral delivery vehicles for antigens |
| 12/13/2007 | WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor |
| 12/13/2007 | WO2007107996A8 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 12/13/2007 | WO2007101602A3 Chimeric kunitz domains and their use |
| 12/13/2007 | WO2007101191A3 Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors |
| 12/13/2007 | WO2007098415A3 Peptide based inhibition of capcna protein-protein interactions in cancer |
| 12/13/2007 | WO2007096510A3 Strains of lactobacillus helveticuswhich do not ferment lactose |
| 12/13/2007 | WO2007095616A3 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/13/2007 | WO2007093409A3 Mcp-i binding nucleic acids |
| 12/13/2007 | WO2007092059A3 Rna interference mediated inhibition of influenza virus gene expression using short interfering nucleic acid |
| 12/13/2007 | WO2007087503A8 Polypeptides having lipase activity and polynucleotides encoding same |
| 12/13/2007 | WO2007072461A3 Modified proteins comprising a bioactive peptide/protein linked to a sequence of aminoacids containing a human carbohydrate binding module (cbm), and development of a system for the administration of therapeutically active proteins and respective utilizations for biomedical purposes |
| 12/13/2007 | WO2007070687A3 Alteration of plant embryo/endosperm size during seed development |
| 12/13/2007 | WO2007055979A3 Native trre: protein implicated in tnf receptor shedding for treating arthritis and inflammation |
| 12/13/2007 | WO2007046971A3 Antiepileptogenic complex of albumin with docosahexaenoate |
| 12/13/2007 | WO2007021971A3 Labeling compositions and methods of use for deterrent trackability |
| 12/13/2007 | WO2007011479A3 Double-stranded rna stabilized in planta |
| 12/13/2007 | WO2007005581A8 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide=resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
| 12/13/2007 | WO2006138475A3 Mao-b inhibitors useful for treating obesity |
| 12/13/2007 | WO2006138276A3 Improved antimicrobial peptides and uses thereof |
| 12/13/2007 | WO2006123256A8 Hivcon: an hiv immunogen and uses thereof |
| 12/13/2007 | WO2006115548A3 Subunit vaccine against west nile viral infection |
| 12/13/2007 | WO2006081396A3 Compositions and methods for delivery of agents into cells |
| 12/13/2007 | WO2005089182A3 Improved bacterial host cell for the direct expression of peptides |
| 12/13/2007 | WO2005086751A3 Combinatorial interleukin-2 muteins |
| 12/13/2007 | WO2005017103A3 Bacterial nitric oxide synthases and uses thereof |
| 12/13/2007 | WO2001083684A3 A novel polypeptide, a human zinc-finger krab kraz2-13 protein and the polynucleotide encoding the polypeptide |
| 12/13/2007 | WO2001075035A3 A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide |
| 12/13/2007 | US20070289035 Novel epsp synthase genes conferring herbicide resistance |
| 12/13/2007 | US20070289034 Control of Programmed Death(Pcd) in Plants |
| 12/13/2007 | US20070289033 Constructing a expression vector containing an endosperm-specific promoter and a DNA leading sequence encoding an endosperm-specific signal peptide, the gene of the fusion carrier, and a non-storage protein as fusion carrier; transforming a plant cell with the vector; and regenerating a mature plant |
| 12/13/2007 | US20070289032 Agrobacterium transformation of guar |
| 12/13/2007 | US20070289029 Means and Methods for Producing a Stabilized Cell of Interest |
| 12/13/2007 | US20070287834 Method for mutation detection in HIV-1 using pol sequencing |
| 12/13/2007 | US20070287833 siRNA targeting minichromosome maintenance deficient 6 (MCM6) |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system |
| 12/13/2007 | US20070287680 Combined Active and Passive Targeting of Biologically Active Agents |
| 12/13/2007 | US20070287678 Anti-aging micrornas |
| 12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
| 12/13/2007 | US20070287667 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits |
| 12/13/2007 | US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders |
| 12/13/2007 | US20070287629 Detecting ligand binding to the complex of the protein; for identifying and selecting a protein or protein complex with increased affinity to a ligand, relates to nucleic acid molecules encoding PMA or 14-3-3 with decreased affinity to a ligand and to methods of generating transgenic plants |
| 12/13/2007 | US20070287189 bioinformatics; use of computer database to identify zinc finger proteins to target sites such as oncogenes |
| 12/13/2007 | US20070287180 Linear Dna Fragment For Markerless Deletion, Novel Strain Having Inhibited Formation Of Biofilm And Preparation Method Thereof |
| 12/13/2007 | US20070287179 Inhibiting ribonucleoprotein particles (miRNPs) activity in a cell |
| 12/13/2007 | US20070287175 Sirna That Inhibits Wt1 Gene Expression And Uses Thereof |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070287167 Dual-Transfected Cells Lines As In Vitro Screening Tools For Pharmaceutical Compound Profiling: A Model For The Heptobiliary Elimination |
| 12/13/2007 | US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia |
| 12/13/2007 | US20070287155 Processes for detecting toxic substances |
| 12/13/2007 | US20070287154 Canine Tas1r1, Tas1r2, and Tas1r3 receptor genes; screening for compounds that modify the genes' function or activity; modifying taste preferences, ingestive responses, or general behavior of a mammal such as a dog by administering compounds that affect the function or activity of the gene |
| 12/13/2007 | US20070287153 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 12/13/2007 | US20070287151 Methods and Means for Nucleic Acid Sequencing |
| 12/13/2007 | US20070287150 Methods And Compositions Involving S-Ship Promoter Regions |
| 12/13/2007 | US20070287146 Method for expressing a functional membrane-bound receptor protein using budded baculovirus |
| 12/13/2007 | US20070286873 Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis |
| 12/13/2007 | US20070286860 Compositions and Methods for Inducing Anti-Tumor Immunity |
| 12/13/2007 | US20070286851 Method of Identifying Modulators of NOGO-Functions |
| 12/13/2007 | US20070286850 Mevalonate Kinase |
| 12/13/2007 | US20070286848 Epas1 Gene Transfer to Improve Cell Therapy |
| 12/13/2007 | US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |